Its expression is induced by factors associated with infections, injury, hypoxia and inflammation, through signaling pathways involving NF-κB activation; contrarily, it is decreased by anti-inflammatory cytokines, resolvins and glucocorticoids, thus providing a feedback inhibition of the miR-155-induced responses [108]. The gene discussed is NFKB1; the disease is infection.